Biological Industries
 | This article needs additional citations for verification. (November 2015) |
Biological Industries is an Israel multinational, chemicals and biotechnology company, headquartered in Israel, with R&D and scientific training centers in Europe and the United States.[1] The company provides product development and cell culture services to the pharmaceutical and biological industries, including custom manufacturing of biopharmaceuticals, and custom cell culture media formulations.
History[edit]
Biological Industries (BI) was founded in 1982 in the northern Kibbutz Beit Haemek, Israel.[2] The company has expanded in the United States through joint ownership owned by PEM BioGroup LLC of Windsor.[3] Initially the company produced FBS and basic cell culture manufacturing for research and also distributes for multiple companies worldwide.[4] BI has developed cytogenetics media and stem cell culture media to include media for freezing and thawing human pluripotent stem cells.
Publications[edit]
- An effective freezing/thawing method for human pluripotent stem cells cultured in chemically-defined and feeder-free conditions
- Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report
External links[edit]
References[edit]
- ^ "Biological Industries Expands to the United States, Providing Innovative Research Technology to the U.S. Life Sciences Market".
- ^ "Organization". Biological Industries. Retrieved November 19, 2016.
- ^ "Israel cell manufacturer firm opening Cromwell location". Hartford Business Review.
- ^ "Biological Industries named exclusive distributor of ATCC products in Israel".